High Frequencies

 
News Articles for High Frequencies top ^
2015/1/15
By Steve Goldstein, MarketWatch WASHINGTON (MarketWatch) -- The Securities and Exchange Commission on Thursday announced its third case in four days over alleged high-frequency trading abuses, this time charging UBS with not disclosing an order type that allowed some traders to jump ahead of others.
Sign-up for SEC brings third high-frequency trading case in four days investment picks
2015/1/26
By Eric Garcia, MarketWatch WASHINGTON (MarketWatch) -- The New York attorney general's complaint against a leading bank's dark pool activity named many high-frequency trading firms that support Washington's lobbyist on the practice.
Sign-up for Firms behind high-frequency trading lobby prominent in Barclays complaint investment picks
2015/1/15
By Steve Goldstein, MarketWatch WASHINGTON (MarketWatch) -- The Securities and Exchange Commission on Thursday announced its third case in four days over alleged high-frequency trading abuses, this time charging UBS with not disclosing an order type that allowed some traders to jump ahead of others.
Sign-up for UPDATE: SEC brings third high-frequency-trading case in four days investment picks
2015/1/15
By Steve Goldstein, MarketWatch WASHINGTON (MarketWatch) -- The Securities and Exchange Commission on Thursday announced its third case in four days over alleged high-frequency trading abuses, this time charging UBS with not disclosing an order type that allowed some traders to jump ahead of others.
Sign-up for UPDATE: SEC brings third high-frequency trading case in four days investment picks
2015/1/9
Foundation Medicine, Inc. (NASDAQ:FMI) today announced that FoundationOne® , the company's flagship comprehensive genomic profile for patients with solid tumors, successfully identified clinically relevant genomic alterations in 65 percent of patients with lung adenocarcinoma whose tumors previously tested negative for alterations using multiple conventional approaches.
Sign-up for FoundationOne® Identifies High Frequency of Clinically Relevant Genomic Alterations (GA) Previously Missed by Conventional Genomic Tests, Enabling Successful Targeted Treatment in Patients with Non-Small Cell Lung Cancer investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
High Frequencies
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: High ETF  |  Next: High Fund Prices